Medicine

• The US Administration is restructuring the systems supporting PEPFAR and global health security, shifting its engagement strategy toward regulatory influence over long-term public health partnerships. • Concerns are rising that increased political oversight and the deconstruction of international collaborations may undermine the NIH's scientific infrastructure and its history of HIV research and vaccine development. • In a move toward regulatory cooperation, the US Food and Drug Administration (FDA) and the African Medicines Agency (AMA) signed a Memorandum of Understanding (MoU) to establish a shared framework for information sharing.

• UC San Diego engineers are researching the ability to grow plants under simulated space conditions to produce essential pharmaceuticals during long-term missions. • The initiative addresses a critical safety gap, as medications degrade faster in space; studies show over half of the International Space Station's drug supply expires within three years. • This biological production method is vital for deep-space travel, such as a round trip to Mars, which requires approximately 400 days of travel time.

• The Vanderbilt Report's weekly briefing for June 1–8, 2026, highlights several major medical breakthroughs, including new findings regarding GLP-1 weight-loss drugs. • Key developments include the discovery of a "striking new cancer signal" associated with GLP-1 medications and the emergence of a one-shot gene editing infusion. • These advancements are significant as they potentially expand the therapeutic use of weight-loss drugs and simplify the delivery of genetic treatments.

• New research on mice suggests that a common anti-aging drug combination may cause brain damage, specifically severe myelin loss and symptoms similar to "chemo brain." • A review of 17 studies indicates that guava juice can significantly improve anemia in women and teenage girls by enhancing the body's iron absorption. • These findings highlight critical risks associated with longevity treatments and offer a dietary alternative for managing iron deficiency.

• Researchers are testing a novel approach to treating depression by using anti-inflammatory drugs to calm the immune system rather than targeting brain chemicals. • In a small clinical trial conducted around May 28, 2026, early results indicate that reducing systemic inflammation may alleviate depressive symptoms. • This discovery is significant because it suggests a biological link between the immune system and mental health, potentially offering an alternative for patients who do not respond to traditional antidepressants.

• A survey by Rutgers University and partner institutions found Americans disapprove of Trump administration policies targeting science and medicine by a margin exceeding 2-to-1, reflecting broad public opposition. • The polling data indicates significant public concern about the administration's approach to scientific research funding and medical policy implementation. • The survey results underscore ongoing public health and science policy controversies during the current administration's tenure.

• U.S. News & World Report published its fourth annual Best OTC Medicine & Health Products rankings on May 12, 2026, evaluating brands in categories from supplements to skincare and menopause products. • Nature Made topped the list with 12 No. 1 products, followed by CeraVe with 6 and La Roche-Posay with 4; companies like Haleon, Pharmavite, Kenvue, L'Oreal, and Prestige Consumer Healthcare led in top rankings. • The rankings provide consumer guidance on over-the-counter health products amid rising demand for specialized supplements like collagen and menopause aids.

• The American College of Emergency Physicians reports a record 3,058 positions filled in emergency medicine residencies, signaling rebound from pandemic-era lows. • More applicants matched into emergency medicine than ever before, as of March 18, 2026. • This surge addresses physician shortages in high-demand ERs across US hospitals.